Skip to Content
Søg Menu

Pieter Sonneveld

A Potential New Standard of Care for Transplant-Eligible Patients with Multiple Myeloma

/ Pieter Sonneveld
ASH23Myelomatose Play the Video 05:04

ASH 2023: The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated CLL

/ BestPractice Nordic
ASH23CLL
Jeff P. Sharman

No Increased Risk of Ventricular Arrhythmias and Sudden Death with Acalabrutinib

/ Jeff P. Sharman
ASH23CLL Play the Video 1:45
Gabriel Brisou

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B-Cell Lymphoma

/ Gabriel Brisou
ASH23B-celle lymfom Play the Video 2:39

ASH 2023: FDA Approves Gene Therapies for Sickle Cell Disease

/ BestPractice Nordic
ASH23

When IBS Causes Cognitive Difficulties Affecting Everyday Life

/ Julie E. Billing / Astri J. Lundervold
IBS
Hamish Scott & Chris Hahn

ERG Deficiency Syndrome - Maybe a New Disease

/ Hamish S. Scott / Christopher Hahn
ASH23 Play the Video 4:48
Jeff P. Sharman

Acalabrutinib in Frontline CLL Treatment: Six-Year Results from the Elevate-TN Study

/ Jeff P. Sharman
ASH23CLL Play the Video 2:45
Amer Zeidan

New Data on Oral Decitabine in MDS: Real-Life Analysis and Outcomes from ASH2023

/ Amer Zeidan
ASH23 Play the Video 2:53
Martin Hutchings

Opdaterede data viser fortsat komplet respons hos over 50% af patienter behandlet med glofitamab for r/r storcellet B-celle lymfom

/ Martin Hutchings
ASH23B-celle lymfomLymfom Play the Video 4:05
Back to top